RANDOMIZED CLINICAL TRIAL TO ASSESS THE EFFECT OF RAJANYADI SYRUP IN THE MANAGEMENT OF PANDU W.S.R. TO IRON DEFICIENCY ANEMIA (IDA) IN CHILDREN

RANDOMIZED CLINICAL TRIAL TO ASSESS THE EFFECT OF RAJANYADI SYRUP IN THE MANAGEMENT OF PANDU W.S.R. TO IRON DEFICIENCY ANEMIA (IDA) IN CHILDREN - nil

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/04/008432

Enrollment

Registered

2017-04-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- iron deficency

Interventions

Intervention1: rajanyadi syrup: 2-5Years 10ml (in 2 divided doses) 6-9years 20ml (in 2 divided doses) 10-12years 25ml (in 2 divided doses) Duration: 8weeks Follow up: 4weeks Control Intervention1: F

Eligibility

Inclusion criteria

Inclusion criteria: Children of 2-12 years of age of either sex Hemoglobin count below 11.5gm/dl (WHO guideline) Patients having classical sign and symptoms of Pandu Roga

Exclusion criteria

Exclusion criteria: Age below 2years and above 12 years Hemoglobin count below 6.5gm/dl Hemoglobinopathies especially thalassemias, sickle cell anemia, aplastic anemia etc. Sprue syndrome, Worm infestation Chronic illness like TB, CA etc. ï?·Juvenile disorders like DM, RA etc.

Design outcomes

Primary

Measure	Time frame
increases the iron level in children reduces idaTimepoint: 12 weeks	—

Secondary

Measure	Time frame
reduces the wekness,increse general healt,helps to produce normal mcv,mch,mchc,and pcv valvesTimepoint: 12 weeks	—

Countries

India

Contacts

Public ContactDr Sunil P Changle

parul institue of ayurveda

sunilchangle16@gmail.com9687613916

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026